{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:45:44Z","timestamp":1782863144950,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Nanjing Traditional Chinese Medicine Science and Technology Special Project","award":["ZYQN202206"],"award-info":[{"award-number":["ZYQN202206"]}]},{"name":"Nanjing Traditional Chinese Medicine Youth Talent Cultivation Project","award":["NJSZYYQNRC-2020-CX"],"award-info":[{"award-number":["NJSZYYQNRC-2020-CX"]}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Natural Science Foundation","doi-asserted-by":"crossref","award":["BK20221424)"],"award-info":[{"award-number":["BK20221424)"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11918-4","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:54:57Z","timestamp":1778648097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-548as-5p promotes breast cancer cell apoptosis and improves tamoxifen resistance by downregulating NF-\u03baB1"],"prefix":"10.1007","volume":"53","author":[{"given":"Xu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3355-0816","authenticated-orcid":false,"given":"Dongchen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"11918_CR1","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1097\/CM9.0000000000003278","volume":"137","author":"K Sun","year":"2024","unstructured":"Sun K, Zhang B, Lei S et al (2024) Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022. Chin Med J (Engl) 137:2429\u20132436. https:\/\/doi.org\/10.1097\/CM9.0000000000003278","journal-title":"Chin Med J (Engl)"},{"key":"11918_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrclinonc.2015.117","volume":"12","author":"R Jeselsohn","year":"2015","unstructured":"Jeselsohn R, Buchwalter G, De Angelis C, Brown M, Schiff R (2015) ESR1 mutations\u2014a mechanism for acquired endocrine resistance in breast cancer. Nat Rev Clin Oncol 12:573\u2013583. https:\/\/doi.org\/10.1038\/nrclinonc.2015.117","journal-title":"Nat Rev Clin Oncol"},{"key":"11918_CR3","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1007\/s11010-025-05304-0","volume":"480","author":"S Javankiani","year":"2025","unstructured":"Javankiani S, Bolandi S, Soleimani A et al (2025) MAPK signaling mediates tamoxifen resistance in estrogen receptor-positive breast cancer. Mol Cell Biochem 480:4973\u20134989. https:\/\/doi.org\/10.1007\/s11010-025-05304-0","journal-title":"Mol Cell Biochem"},{"key":"11918_CR4","doi-asserted-by":"publisher","first-page":"119821","DOI":"10.1016\/j.bbamcr.2024.119821","volume":"1871","author":"M Nakatsuji","year":"2024","unstructured":"Nakatsuji M, Fujimori K (2024) Adipocyte-conditioned medium induces tamoxifen resistance by activating PI3K\/Akt\/mTOR pathway in estrogen receptor-positive breast cancer cells. Biochim Biophys Acta Mol Cell Res 1871:119821. https:\/\/doi.org\/10.1016\/j.bbamcr.2024.119821","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"11918_CR5","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1016\/j.cell.2021.08.036","volume":"184","author":"Y Xu","year":"2021","unstructured":"Xu Y, Huangyang P, Wang Y et al (2021) ER\u03b1 is an RNA-binding protein sustaining tumor cell survival and drug resistance. Cell 184:5215\u20135229e17. https:\/\/doi.org\/10.1016\/j.cell.2021.08.036","journal-title":"Cell"},{"key":"11918_CR6","doi-asserted-by":"publisher","first-page":"122684","DOI":"10.1016\/j.lfs.2024.122684","volume":"348","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Lin M, Zeng C, Zhang J (2024) NF-\u03baB signaling in therapy resistance of breast cancer: mechanisms, approaches, and challenges. Life Sci 348:122684. https:\/\/doi.org\/10.1016\/j.lfs.2024.122684","journal-title":"Life Sci"},{"key":"11918_CR7","first-page":"152","volume":"25","author":"J Hu","year":"2020","unstructured":"Hu J, Guo P, Zhang Y, Huang Z, Chen B (2020) MicroRNA-322 regulates the growth, chemosensitivity, migration and invasion of breast cancer cells by targeting NF-kB1. J BUON 25:152\u2013158","journal-title":"J BUON"},{"key":"11918_CR8","doi-asserted-by":"publisher","first-page":"9499","DOI":"10.1007\/s00210-025-03936-z","volume":"398","author":"EAV Beilankouhi","year":"2025","unstructured":"Beilankouhi EAV, Safaralizadeh R, Nejati B et al (2025) miRNAs as emerging predictors of tamoxifen resistance in breast cancer. Naunyn Schmiedebergs Arch Pharmacol 398:9499\u20139515. https:\/\/doi.org\/10.1007\/s00210-025-03936-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"11918_CR9","doi-asserted-by":"publisher","first-page":"29897","DOI":"10.1074\/jbc.M804612200","volume":"283","author":"TE Miller","year":"2008","unstructured":"Miller TE, Ghoshal K, Ramaswamy B et al (2008) MicroRNA-221\/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 283:29897\u201329903. https:\/\/doi.org\/10.1074\/jbc.M804612200","journal-title":"J Biol Chem"},{"key":"11918_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10549-014-3037-0","volume":"147","author":"Y Wei","year":"2014","unstructured":"Wei Y, Lai X, Yu S et al (2014) Exosomal miR-221\/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Res Treat 147:423\u2013431. https:\/\/doi.org\/10.1007\/s10549-014-3037-0","journal-title":"Breast Cancer Res Treat"},{"key":"11918_CR11","doi-asserted-by":"publisher","first-page":"116434","DOI":"10.1016\/j.intimp.2026.116434","volume":"175","author":"D Xue","year":"2026","unstructured":"Xue D, Xie Y, Sun J et al (2026) MicroRNA-375 promotes tamoxifen resistance by stabilizing ER\u03b1 via UBE3A-mediated ubiquitination. Int Immunopharmacol 175:116434. https:\/\/doi.org\/10.1016\/j.intimp.2026.116434","journal-title":"Int Immunopharmacol"},{"key":"11918_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/path.4363","volume":"233","author":"A Ward","year":"2014","unstructured":"Ward A, Shukla K, Balwierz A et al (2014) MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer. J Pathol 233:368\u2013379. https:\/\/doi.org\/10.1002\/path.4363","journal-title":"J Pathol"},{"key":"11918_CR13","doi-asserted-by":"publisher","first-page":"57239","DOI":"10.18632\/oncotarget.11136","volume":"7","author":"T Joshi","year":"2016","unstructured":"Joshi T, Elias D, Stenvang J et al (2016) Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer. Oncotarget 7:57239\u201357253. https:\/\/doi.org\/10.18632\/oncotarget.11136","journal-title":"Oncotarget"},{"key":"11918_CR14","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1038\/s41598-025-86287-2","volume":"15","author":"H Yuan","year":"2025","unstructured":"Yuan H, Zhou L, Hu W, Yang M (2025) LINC00626 drives tamoxifen resistance in breast cancer cells by interaction with UPF1. Sci Rep 15:2997. https:\/\/doi.org\/10.1038\/s41598-025-86287-2","journal-title":"Sci Rep"},{"key":"11918_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/biology14050496","volume":"14","author":"Z Chen","year":"2025","unstructured":"Chen Z, Zhong Y, Chen L et al (2025) HGF aggravated periodontitis-associated gut barrier and microbial dysfunction: implications for oral-gut axis regulation. Biology (Basel) 14:496. https:\/\/doi.org\/10.3390\/biology14050496","journal-title":"Biology (Basel)"},{"key":"11918_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2^(\u2013\u2206\u2206CT) method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"11918_CR17","unstructured":"TargetScan 7.2. https:\/\/www.targetscan.org\/vert_72\/. Accessed 12 April (2026)"},{"key":"11918_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.it.2008.07.003","volume":"29","author":"S-C Sun","year":"2008","unstructured":"Sun S-C, Ley SC (2008) New insights into NF-\u03baB regulation and function. Trends Immunol 29:469\u2013478. https:\/\/doi.org\/10.1016\/j.it.2008.07.003","journal-title":"Trends Immunol"},{"key":"11918_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrc3204","volume":"12","author":"ND Perkins","year":"2012","unstructured":"Perkins ND (2012) The diverse and complex roles of NF-\u03baB subunits in cancer. Nat Rev Cancer 12:121\u2013132. https:\/\/doi.org\/10.1038\/nrc3204","journal-title":"Nat Rev Cancer"},{"key":"11918_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/CBM-150546","volume":"16","author":"E Eskandari-Nasab","year":"2016","unstructured":"Eskandari-Nasab E, Hashemi M, Ebrahimi M, Amininia S (2016) The functional 4-bp insertion\/deletion ATTG polymorphism in the promoter region of NF-kB1 reduces the risk of BC. Cancer Biomark 16:109\u2013115. https:\/\/doi.org\/10.3233\/CBM-150546","journal-title":"Cancer Biomark"},{"key":"11918_CR21","doi-asserted-by":"publisher","first-page":"14608","DOI":"10.1038\/s41598-023-41438-1","volume":"13","author":"Z Darabi","year":"2023","unstructured":"Darabi Z, Seyed Hosseini SM, Sarebanhassanabadi M et al (2023) Interaction of dietary patterns with rs28362491 on severity of coronary artery stenosis in patients undergoing coronary angiography. Sci Rep 13:14608. https:\/\/doi.org\/10.1038\/s41598-023-41438-1","journal-title":"Sci Rep"},{"key":"11918_CR22","doi-asserted-by":"publisher","first-page":"682596","DOI":"10.3389\/fonc.2021.682596","volume":"11","author":"HMA El-Fadl","year":"2021","unstructured":"El-Fadl HMA, Hagag NM, El-Shafei RA et al (2021) Effective targeting of Raf-1 and its associated autophagy by novel extracted peptide for treating breast cancer cells. Front Oncol 11:682596. https:\/\/doi.org\/10.3389\/fonc.2021.682596","journal-title":"Front Oncol"},{"key":"11918_CR23","doi-asserted-by":"publisher","first-page":"8905","DOI":"10.12659\/MSM.918384","volume":"25","author":"X Liu","year":"2019","unstructured":"Liu X, Huang J, Xie Y, Zhou Y, Wang R, Lou J (2019) Napabucasin attenuates resistance of breast cancer cells to tamoxifen by reducing stem cell-like properties. Med Sci Monit 25:8905\u20138912","journal-title":"Med Sci Monit"},{"key":"11918_CR24","doi-asserted-by":"publisher","first-page":"32575","DOI":"10.18632\/oncotarget.5331","volume":"6","author":"Y Chen","year":"2015","unstructured":"Chen Y, Gou X, Kong DK et al (2015) EMMPRIN regulates tumor growth and metastasis by recruiting bone marrow-derived cells through paracrine signaling of SDF-1 and VEGF. Oncotarget 6:32575\u201332585. https:\/\/doi.org\/10.18632\/oncotarget.5331","journal-title":"Oncotarget"},{"key":"11918_CR25","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3892\/or.2016.4930","volume":"36","author":"S Borska","year":"2016","unstructured":"Borska S, Pedziwiatr M, Danielewicz M et al (2016) Classical and atypical resistance of cancer cells as a target for resveratrol. Oncol Rep 36:1562\u20131568. https:\/\/doi.org\/10.3892\/or.2016.4930","journal-title":"Oncol Rep"},{"key":"11918_CR26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10616-020-00418-3","volume":"72","author":"P-Y Tan","year":"2020","unstructured":"Tan P-Y, Wen L-J, Li H-N, Chai S-W (2020) MiR-548c-3p inhibits the proliferation, migration and invasion of human breast cancer cell by targeting E2F3. Cytotechnology 72:751\u2013761. https:\/\/doi.org\/10.1007\/s10616-020-00418-3","journal-title":"Cytotechnology"},{"key":"11918_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.breast.2018.10.002","volume":"42","author":"M Mansouri Bidkani","year":"2018","unstructured":"Mansouri Bidkani M, Tabatabaeian H, Parsafar S, Ghanei N, Fazilati M, Ghaedi K (2018) ErbB4 receptor polymorphism 2368A\u2009>\u2009C and risk of breast cancer. Breast 42:157\u2013163. https:\/\/doi.org\/10.1016\/j.breast.2018.10.002","journal-title":"Breast"},{"key":"11918_CR28","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1158\/1541-7786.MCR-19-1082","volume":"18","author":"I Kastrati","year":"2020","unstructured":"Kastrati I, Joosten SEP, Semina SE et al (2020) The NF-\u03baB pathway promotes tamoxifen tolerance and disease recurrence in estrogen receptor-positive breast cancers. Mol Cancer Res 18:1018\u20131027. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-1082","journal-title":"Mol Cancer Res"},{"key":"11918_CR29","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1158\/1078-0432.CCR-23-1248","volume":"29","author":"H Kim","year":"2023","unstructured":"Kim H, Whitman AA, Wisniewska K et al (2023) Tamoxifen response at single-cell resolution in estrogen receptor-positive primary human breast tumors. Clin Cancer Res 29:4894\u20134907. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1248","journal-title":"Clin Cancer Res"},{"key":"11918_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1290\/1071-2690(2000)036<0447:EMAIIP>2.0.CO;2","volume":"36","author":"JE Moreno-Cuevas","year":"2000","unstructured":"Moreno-Cuevas JE, Sirbasku DA (2000) Estrogen mitogenic action. III. is phenol red a red herring? Vitro Cell Dev Biol Anim 36:447\u2013464. https:\/\/doi.org\/10.1290\/1071-2690(2000)036","journal-title":"Vitro Cell Dev Biol Anim"},{"key":"11918_CR31","doi-asserted-by":"publisher","first-page":"21933","DOI":"10.1038\/s41598-020-78833-x","volume":"10","author":"L Hamadneh","year":"2020","unstructured":"Hamadneh L, Abuarqoub R, Alhusban A, Bahader M (2020) Upregulation of PI3K\/AKT\/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells. Sci Rep 10:21933. https:\/\/doi.org\/10.1038\/s41598-020-78833-x","journal-title":"Sci Rep"},{"key":"11918_CR32","doi-asserted-by":"publisher","unstructured":"Cao J, Zhou T, Wu T et al (2025) Targeting estrogen-regulated system xc- promotes ferroptosis and endocrine sensitivity of ER+ breast cancer. Cell Death Dis 16(1):30. https:\/\/doi.org\/10.1038\/s41419-025-07354-0","DOI":"10.1038\/s41419-025-07354-0"},{"key":"11918_CR33","doi-asserted-by":"publisher","first-page":"7493","DOI":"10.1158\/0008-5472.CAN-08-1404","volume":"68","author":"CJ Creighton","year":"2008","unstructured":"Creighton CJ, Massarweh S, Huang S et al (2008) Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts. Cancer Res 68:7493\u20137501. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1404","journal-title":"Cancer Res"}],"updated-by":[{"DOI":"10.1007\/s11033-026-12134-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000}}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11918-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11918-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11918-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:47:36Z","timestamp":1782859656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11918-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11918"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11918-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Figures 1, 2, 3, and 5 have been updated and details of reference 32 has been corrected","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11033-026-12134-w","URL":"https:\/\/doi.org\/10.1007\/s11033-026-12134-w","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures conducted in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. The animal experiment was approved by the Institutional Animal Care and Use Committee of Nanjing Ramda Pharmaceutical Co., Ltd. (No. IACUC-20240715, dated July 12, 2024) and conducted per the Animal Care Committee guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"751"}}